glutathione mutations in sclc patients Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation non-small-cell-lung-cancer Cell Death, Molecular Targeted Therapies,
Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR Mutant Lung Cancer In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology glutathione mutations in sclc patients Role of Cancer: From Mechanisms to Therapies Deep Clustering Based Metabolic Stratification of
Pay in 4 interest-free payments of $7.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



